Risk Factors for Local Recurrence of Primary Cutaneous Squamous Cell Carcinomas

Dzubow, Leonard M.

doi:10.1001/archderm.1982.01650230028021

Cited by 70 publications

(23 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Griffiths et al estimated BCC recurrence rates after conventional surgical excision to be between 1.3% and 2% over a minimum of 5 years follow up 44 . For primary SCCs, reported 5‐year recurrence rates range from 3% to 8% 45–47 for completely excised tumors and are unknown for incompletely excised SCC. For SCC in situ , reported 5‐year recurrence rates range from 6.3% after Mohs surgery 48 to 5–19% after surgical excision 49,50 …”

Section: Discussionmentioning

confidence: 99%

Recurrence rates associated with incompletely excised low‐risk nonmelanoma skin cancer

Rieger¹,

Linos²,

Egbert

et al. 2009

J Cutan Pathol

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Recurrence rates associated with incompletely excised low‐risk nonmelanoma skin cancer

Rieger¹,

Linos²,

Egbert

et al. 2009

J Cutan Pathol

View full text Add to dashboard Cite

show abstract

“…52 Since about 90 percent of recurrences and metastases occur during the first five years after treatment, screening during this period may be adequate. [53][54][55] Organ-transplant recipients should undergo regular screening examinations regardless of whether they have any history of skin cancer. 56 According to commonly accepted guidelines, patients who have a history of nonmelanoma skin cancer or who have predisposing conditions should undergo screening once or twice yearly.…”

Section: Screening and Detectionmentioning

confidence: 99%

Cutaneous Squamous-Cell Carcinoma

2001

View full text Add to dashboard Cite

“…We did not do a pooled analysis of other features considered to confer high risk owing to different reporting methods in the studies in which these factors were considered. Increased risk of recurrence with tumours > 2 cm was noted in some of the included studies, 544,551,573 although this finding was not supported by Mourouzis et al, 553 with 60% of metastases originating in SCCs < 2 cm, nor by Dzubow et al, 570 who found a trend towards significance with tumours > 5 cm in diameter. Several studies showed the importance of SCC depth as a risk factor for recurrence.…”

Section: Stratification Of Riskmentioning

confidence: 80%

“…545,558,[564][565][566][567][568][569][570][571][572][573][574][575][576][577] In a seminal series of papers, Mohs reported 5-year cure rates for previously untreated SCCs of 95.7% for SCC of the trunk and extremities; 578 96.6% for the ear; 579 97.8% for facial, scalp and neck SCCs; 578 98.5% for eyelid SCCs; 580 and 98.8% for SCCs of the nose. 578 These rates translated to a pooled 5-year cure rate 97.4% for the 2133 SCCs at all sites (95% CI 96.2% to 98.3%; I 2 = 48%).…”

Section: Mohs Micrographic Surgerymentioning

confidence: 99%

A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease

Kim

Batchelor

Bath‐Hextall

et al. 2016

Programme Grants Appl Res

View full text Add to dashboard Cite

Programme Grants for Applied ResearchISSN 2050-4322 (Print) ISSN 2050-4330 (Online) This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE) (www.publicationethics.org/).Editorial contact: nihredit@southampton.ac.ukThe full PGfAR archive is freely available to view online at www.journalslibrary.nihr.ac.uk/pgfar. Print-on-demand copies can be purchased from the report pages of the NIHR Journals Library website: www.journalslibrary.nihr.ac.uk Criteria for inclusion in the Programme Grants for Applied Research journalReports are published in Programme Grants for Applied Research (PGfAR) if (1) they have resulted from work for the PGfAR programme, and (2) they are of a sufficiently high scientific quality as assessed by the reviewers and editors. Programme Grants for Applied Research programmeThe Programme Grants for Applied Research (PGfAR) programme, part of the National Institute for Health Research (NIHR), was set up in 2006 to produce independent research findings that will have practical application for the benefit of patients and the NHS in the relatively near future. The Programme is managed by the NIHR Central Commissioning Facility (CCF) with strategic input from the Programme Director.The programme is a national response mode funding scheme that aims to provide evidence to improve health outcomes in England through promotion of health, prevention of ill health, and optimal disease management (including safety and quality), with particular emphasis on conditions causing significant disease burden.For more information about the PGfAR programme please visit the website: http://www.nihr.ac.uk/funding/programme-grants-forapplied-research.htm This reportThe research reported in this issue of the journal was funded by PGfAR as project number RP-PG-0407-10177. The contractual start date was in September 2008. The final report began editorial review in April 2014 and was accepted for publication in April 2016. As the funder, the PGfAR programme agreed the research questions and study designs in advance with the investigators. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The PGfAR editors and production house have tried to ensure the accuracy of the authors' report and would like to thank the reviewers for their constructive comments on the final report document. However, they do not accept liability for damages or losses arising from material published in this report.This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, CCF, NETSCC, PGfAR or the Department of Health. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, ...

show abstract

Risk Factors for Local Recurrence of Primary Cutaneous Squamous Cell Carcinomas

Cited by 70 publications

References 7 publications

Recurrence rates associated with incompletely excised low‐risk nonmelanoma skin cancer

Recurrence rates associated with incompletely excised low‐risk nonmelanoma skin cancer

Cutaneous Squamous-Cell Carcinoma

A programme of research to set priorities and reduce uncertainties for the prevention and treatment of skin disease

Contact Info

Product

Resources

About